Your browser doesn't support javascript.
loading
Outcomes of Patients with Child-Pugh B and Unresectable Hepatocellular Carcinoma Undergoing First-Line Systemic Treatment with Sorafenib, Lenvatinib, or Atezolizumab Plus Bevacizumab.
Kikugawa, Chihiro; Uchikawa, Shinsuke; Kawaoka, Tomokazu; Kinami, Takahiro; Yano, Shigeki; Amioka, Kei; Naruto, Kensuke; Ando, Yuwa; Yamaoka, Kenji; Tsuge, Masataka; Kosaka, Yumi; Ohya, Kazuki; Mori, Nami; Takaki, Shintaro; Tsuji, Keiji; Kouno, Hirotaka; Kohno, Hiroshi; Morio, Kei; Moriya, Takashi; Nonaka, Michihiro; Aisaka, Yasuyuki; Masaki, Keiichi; Honda, Yohji; Naeshiro, Noriaki; Hiramatsu, Akira; Aikata, Hiroshi; Oka, Shiro.
Afiliação
  • Kikugawa C; Department of Gastroenterology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Higashihiroshima, Japan, d205972@hiroshima-u.ac.jp.
  • Uchikawa S; Research Center for Hepatology and Gastroenterology, Hiroshima University, Higashihiroshima, Japan, d205972@hiroshima-u.ac.jp.
  • Kawaoka T; Department of Gastroenterology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Higashihiroshima, Japan.
  • Kinami T; Research Center for Hepatology and Gastroenterology, Hiroshima University, Higashihiroshima, Japan.
  • Yano S; Department of Gastroenterology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Higashihiroshima, Japan.
  • Amioka K; Research Center for Hepatology and Gastroenterology, Hiroshima University, Higashihiroshima, Japan.
  • Naruto K; Department of Gastroenterology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Higashihiroshima, Japan.
  • Ando Y; Research Center for Hepatology and Gastroenterology, Hiroshima University, Higashihiroshima, Japan.
  • Yamaoka K; Department of Gastroenterology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Higashihiroshima, Japan.
  • Tsuge M; Research Center for Hepatology and Gastroenterology, Hiroshima University, Higashihiroshima, Japan.
  • Kosaka Y; Department of Gastroenterology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Higashihiroshima, Japan.
  • Ohya K; Research Center for Hepatology and Gastroenterology, Hiroshima University, Higashihiroshima, Japan.
  • Mori N; Department of Gastroenterology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Higashihiroshima, Japan.
  • Takaki S; Research Center for Hepatology and Gastroenterology, Hiroshima University, Higashihiroshima, Japan.
  • Tsuji K; Department of Gastroenterology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Higashihiroshima, Japan.
  • Kouno H; Research Center for Hepatology and Gastroenterology, Hiroshima University, Higashihiroshima, Japan.
  • Kohno H; Department of Gastroenterology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Higashihiroshima, Japan.
  • Morio K; Research Center for Hepatology and Gastroenterology, Hiroshima University, Higashihiroshima, Japan.
  • Moriya T; Department of Gastroenterology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Higashihiroshima, Japan.
  • Nonaka M; Research Center for Hepatology and Gastroenterology, Hiroshima University, Higashihiroshima, Japan.
  • Aisaka Y; Department of Gastroenterology, Hiroshima Red Cross Hospital and Atomic Bomb Survivors Hospital, Hiroshima, Japan.
  • Masaki K; Department of Gastroenterology, Hiroshima Red Cross Hospital and Atomic Bomb Survivors Hospital, Hiroshima, Japan.
  • Honda Y; Department of Gastroenterology, Hiroshima Red Cross Hospital and Atomic Bomb Survivors Hospital, Hiroshima, Japan.
  • Naeshiro N; Department of Gastroenterology, Hiroshima Red Cross Hospital and Atomic Bomb Survivors Hospital, Hiroshima, Japan.
  • Hiramatsu A; Department of Gastroenterology, Hiroshima Red Cross Hospital and Atomic Bomb Survivors Hospital, Hiroshima, Japan.
  • Aikata H; Department of Gastroenterology, National Hospital Organization Kure Medical Center and Chugoku Cancer Center, Hiroshima, Japan.
  • Oka S; Department of Gastroenterology, National Hospital Organization Kure Medical Center and Chugoku Cancer Center, Hiroshima, Japan.
Oncology ; 102(3): 239-251, 2024.
Article em En | MEDLINE | ID: mdl-37729889
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Compostos de Fenilureia / Quinolinas / Carcinoma Hepatocelular / Anticorpos Monoclonais Humanizados / Neoplasias Hepáticas Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Compostos de Fenilureia / Quinolinas / Carcinoma Hepatocelular / Anticorpos Monoclonais Humanizados / Neoplasias Hepáticas Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article